Neuronetics (STIM) Gains from Investment Securities (2017 - 2018)
Neuronetics (STIM) posted quarterly Gains from Investment Securities of -$19000.0 for Q3 2018, down 111.8% year-over-year from $161000.0 in Q3 2017, and down 101.35% quarter-over-quarter from $1.4 million in Q2 2018.
Neuronetics (STIM) Gains from Investment Securities (2017 - 2018) Analysis & Trends
Neuronetics (STIM) has reported Gains from Investment Securities for 2 consecutive years, with -$19000.0 the latest figure, recorded in Q3 2018.
- In Q3 2018, Gains from Investment Securities fell 111.8% year-over-year to -$19000.0; the TTM figure through Dec 2018 stood at $1.4 million (changed N/A YoY), while the FY2018 annual figure was $1.4 million, up 615.13% from the prior year.
- Gains from Investment Securities eased to -$19000.0 in Q3 2018 per STIM's latest filing, from $1.4 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $1.4 million in Q2 2018 and bottomed at -$21000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | Neuronetics | 225.60 Mn | 206.17 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -19,000.00 |
| Sep 30, 2018 | -19,000.00 |
| Jun 30, 2018 | 1.41 Mn |
| Jun 30, 2018 | 1.41 Mn |
| Mar 31, 2018 | 7,000.00 |
| Mar 31, 2018 | 7,000.00 |
| Dec 31, 2017 | -21,000.00 |
| Dec 31, 2017 | -21,000.00 |
| Sep 30, 2017 | 161,000.00 |
| Sep 30, 2017 | 161,000.00 |